Stryker entered into a definitive merger agreement to acquire K2M for ~US $1.4BB in cash. The transaction is slated to close in 4Q18. For 2017, K2M posted revenue of $249.3MM, +8.8% vs. 2016.
Episurf Medical was granted its first patent in Canada (Episealer® Femoral Twin implant) and an additional patent in Australia (3D-based assessment of joint lesions).